The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

Peer Review reports

Original Submission
10 Nov 2013	Submitted	Original manuscript
16 Nov 2013	Reviewed	Reviewer Report - fausto petrelli
18 Nov 2013	Reviewed	Reviewer Report - Kuen-Feng Chen
28 Dec 2013	Author responded	Author comments - Mario Scartozzi
Resubmission - Version 2
28 Dec 2013	Submitted	Manuscript version 2
Publishing
12 Feb 2014	Editorially accepted
20 Feb 2014	Article published	10.1186/1471-2407-14-110

Back to article page